Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Riko Ikeda"'
Publikováno v:
IJU Case Reports, Vol 7, Iss 2, Pp 115-119 (2024)
Introduction The efficacy of olaparib for treatment‐related neuroendocrine prostate cancer is unknown. Here, we report a case of treatment‐related neuroendocrine prostate cancer with a BRCA2 mutation that was treated with olaparib with 1‐year e
Externí odkaz:
https://doaj.org/article/822a7eb106a34c9a8305a49dc6c19ff2
Publikováno v:
Urology Case Reports, Vol 45, Iss , Pp 102227- (2022)
Large cell calcifying Sertoli tumor is an uncommon testicular neoplasm. We present a case of a 36-year-old man with a late-onset large cell calcifying Sertoli tumor that resulted in a solitary lung metastasis 5 years after radical orchiectomy. Pulmon
Externí odkaz:
https://doaj.org/article/84b2e0937c8f4ee1b75f5268f81484ac
Autor:
Yukiko Ikeuchi-Yamamoto, Haruka Kogiso, Daichi Saito, Kotoku Kawaguchi, Riko Ikeda, Shinji Asano, Toshio Inui, Yoshinori Marunaka, Takashi Nakahari
Publikováno v:
Phytomedicine Plus, Vol 2, Iss 2, Pp 100243- (2022)
Background: Hochu-ekki-to (TJ-41, a traditional herbal medicine) is used for preventing airway infections caused by viruss or bacterias in patients with chronic obstructive pulmonary disease (COPD). TJ-41 is known to inhibit viral adhesion and to act
Externí odkaz:
https://doaj.org/article/867328f2ab0e48e89d6fe03c2913b2a6
Autor:
Takahiko Soma, Shohei Fukuda, Yusuke Matsuyama, Riko Ikeda, Masaharu Inoue, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Takeo Fujiwara, Yukio Kageyama, Yasuhisa Fujii
Publikováno v:
International Journal of Urology.
Autor:
Keiji Wakabayashi, Riko Ikeda, Tatsuo Watanabe, Keisuke Ito, Toyomi Yamazaki, Yuki Kuroda, Kazunari Uda
Publikováno v:
Bioscience, Biotechnology, and Biochemistry. 80:2014-2017
Tangeretin and nobiletin are polymethoxylated flavonoids in citrus peel. Both tangeretin and nobiletin are bitter; however, their bitterness has not been evaluated using human bitter taste receptors (hTAS2Rs). We screened 25 kinds of hTAS2Rs and foun
Autor:
Noriko Matsuda, Tsutomu Nakayama, Tatsuo Watanabe, Toyomi Yamazaki, Riko Ikeda, Toshiyuki Nakamura, Takeshi Ishii, Miki Sagisaka
Publikováno v:
Bioscience, biotechnology, and biochemistry. 78(10)
We purified several hundred mgs of four major theaflavins (theaflavin, theaflavin-3-O-gallate, theaflavin-3′-O-gallate, and theaflavin-3,3′-O-digallate). Among the 25 hTAS2Rs expressed in HEK293T cells, hTAS2R39 and hTAS2R14 were activated by the
Autor:
Toyomi Yamazaki, Miki Sagisaka, Riko Ikeda, Toshiyuki Nakamura, Noriko Matsuda, Takeshi Ishii, Tsutomu Nakayama, Tatsuo Watanabe
Publikováno v:
Bioscience, Biotechnology & Biochemistry; Oct2014, Vol. 78 Issue 10, p1753-1756, 4p
Autor:
Soma, Takahiko1 (AUTHOR), Fukuda, Shohei1 (AUTHOR) shouro@tmd.ac.jp, Matsuyama, Yusuke2 (AUTHOR), Ikeda, Riko3 (AUTHOR), Inoue, Masaharu3 (AUTHOR), Waseda, Yuma1 (AUTHOR), Tanaka, Hajime1 (AUTHOR), Yoshida, Soichiro1 (AUTHOR), Yokoyama, Minato1 (AUTHOR), Matsuoka, Yoh3 (AUTHOR), Fujiwara, Takeo2 (AUTHOR), Kageyama, Yukio3 (AUTHOR), Fujii, Yasuhisa1 (AUTHOR)
Publikováno v:
International Journal of Urology. Jun2023, Vol. 30 Issue 6, p532-538. 7p.
Treatment‐related neuroendocrine prostate cancer with BRCA2 germline mutation treated with olaparib.
Autor:
Ikeda, Riko, Matsuoka, Yoh, Inoue, Masaharu, Ishikawa, Ayataka, Akagi, Kiwamu, Kageyama, Yukio
Publikováno v:
IJU Case Reports; Mar2024, Vol. 7 Issue 2, p115-119, 5p
Autor:
Nakamura, Yuki, Ishikawa, Yudai, Matsumoto, Shunya, Ikeda, Riko, Yoshitomi, Kasumi, Kobayashi, Masaki, Fujiwara, Motohiro, Fan, Bo, Fukuda, Shohei, Waseda, Yuma, Tanaka, Hajime, Yoshida, Soichiro, Fujii, Yasuhisa
Publikováno v:
Journal of Urology; 2024 Supplement 5, Vol. 211, pe1161-e1161, 1p